This document contains an investor presentation for an organization providing chronic pain services and medical cannabis telehealth. It discusses the company's growth from $600k in 2018 revenue to $12.6 million in 2020, its network of 9 pain clinics across Canada, and plans for expansion. It also outlines the company's proprietary digital platform, pharmacy initiatives including pharmacist education and patient referrals, and financial overview showing its sources of revenue. The document contains numerous disclaimers regarding forward-looking statements and risks involved in the company's projections.
At Pathway Health, we are committed to delivering personalized care to help improve a patients’ quality of life. We strive to provide patients with timely access to personalized treatment plans using advanced and clinically-proven solutions to achieve the best outcomes.
Pathway Health is an integrated healthcare company that provides advanced products and services to patients suffering from chronic pain and related conditions. The Company owns and operates nine community-based clinics across four provinces where its team of health professionals work together to help patients through a variety of evidence-based approaches and products, including medical cannabis. Pathway's patient care programs utilize an interdisciplinary approach that is guided by trained pain specialists, physical and occupational therapists, psychologists, nurses, and other healthcare providers. Pathway is also the leading provider of medical cannabis services in Canada and has established itself as the collaboration partner with national and regional pharmacy companies for the delivery of medical cannabis services to their customers. The Company is working with several pharmacy companies on the development of Cannabis Health Products (CHPs) for OTC distribution through retail pharmacy locations across the country following anticipated changes to the Cannabis Act.
Global Crossing Airlines provides an investor update on their operations in August 2021. They discuss their FAA certification progress, current and pending charter contracts domestically and internationally, marketing initiatives through their Flugy platform, growing human capital, plans for their Jetlines spin-off, cargo operations, and developing a new airline headquarters and maintenance facility. The update contains forward-looking statements and financial projections that are subject to risks and uncertainties that could cause actual results to differ materially.
Pathway Health is one of the largest providers of out-of-hospital pain management services in . The Company owns and operates 9 community-based clinics across 4 provinces where its team of health professionals work together to help patients through a variety of evidence-based approaches. Pathway Health's patient care programs utilize an interdisciplinary approach that is guided by trained pain specialists, physical and occupational therapists, psychologists, nurses, and other healthcare providers. Pathway Health has also developed an expertise in harm reduction where medicinal cannabis is being used as an alternative to traditional opioids.
Global Crossing Airlines - September 1st 2021 Investor Update WebinarThe Howard Group Inc.
Global Crossing Airlines Group Inc. was incorporated under the laws of British Columbia and continued as a Federal
corporation pursuant to the Canada Business Corporations Act effective February 28, 2017. On February 5, 2020, the
Company entered into a definitive agreement with Global Crossing Airlines, Inc. (“Global USA”), a Delaware
corporation, with respect to a business combination of the Company and Global USA (the “Transaction”). On
December 22, 2020, the Company changed its jurisdiction of incorporation from the Province of British Columbia,
Canada to the State of Delaware (the “U.S. Domestication“). In connection with the U.S. domestication, the Company
changed its name to “Global Crossing Airlines Group, Inc.”
The Company’s principal business activity is the start-up of an aircraft, crew, maintenance, insurance (“ACMI”) and
wet lease US charter airline serving the US, Caribbean and Latin American markets. The address of the Company’s
registered office is office is c/o Cogency Global Inc., 850 New Burton Rd, Suite 201, Dover, County of Kent, Delaware
19904. The Company’s shares trade on the TSX Venture Exchange under the symbol “JET” and are quoted on the
OTCQB under the symbol “JETMF”.
Canada Jetlines is a 100% equity financed and well capitalized low-cost tour and charter leisure carrier that will utilize a growing fleet of Airbus 320 aircraft to service popular sun destinations starting in early 2022, subject to Canadian Transport Agency and Transport Canada approval.
For more information about everything Canada Jetlines, please visit www.jetlines.ca.
About Canada Jetlines Operations Ltd.
Canada Jetlines is a 100-per-cent-equity-financed and well-capitalized leisure carrier, which will utilize a growing fleet of Airbus 320 aircraft targeting a start in early 2022, subject to Canadian Transport Agency and Transport Canada approval. The carrier was created to provide Canadian consumers with more value choices and travel options to fly to coveted sun and leisure destinations in the United States, the Caribbean and Mexico. With a projected growth of 15 aircraft by 2025, Canada Jetlines aims to offer the best-in-class operating economics, customer comfort and fly-by-wire technology, providing an elevated guest-centric experience from the first touch point. The carrier will use a state-of-the-art Web booking platform, making the turnkey solution available to travel agents, tour operators and consumers, with the capability of generating revenue on reservations and ancillary sales. The efficient aircraft design, merged with the experience of the all-Canadian management team, allows for accessible flight options without sacrificing quality or convenience.
Pathway Health is one of the largest providers of out-of-hospital pain management services in Canada. We own and operate nine community-based clinics across four provinces where our team of health professionals work together to help patients by using a variety of evidence-based approaches.
At Pathway Health, we are committed to delivering personalized care to help improve a patients’ quality of life. We strive to provide patients with timely access to personalized treatment plans using advanced and clinically-proven solutions to achieve the best outcomes.
Pathway Health is an integrated healthcare company that provides advanced products and services to patients suffering from chronic pain and related conditions. The Company owns and operates nine community-based clinics across four provinces where its team of health professionals work together to help patients through a variety of evidence-based approaches and products, including medical cannabis. Pathway's patient care programs utilize an interdisciplinary approach that is guided by trained pain specialists, physical and occupational therapists, psychologists, nurses, and other healthcare providers. Pathway is also the leading provider of medical cannabis services in Canada and has established itself as the collaboration partner with national and regional pharmacy companies for the delivery of medical cannabis services to their customers. The Company is working with several pharmacy companies on the development of Cannabis Health Products (CHPs) for OTC distribution through retail pharmacy locations across the country following anticipated changes to the Cannabis Act.
Global Crossing Airlines provides an investor update on their operations in August 2021. They discuss their FAA certification progress, current and pending charter contracts domestically and internationally, marketing initiatives through their Flugy platform, growing human capital, plans for their Jetlines spin-off, cargo operations, and developing a new airline headquarters and maintenance facility. The update contains forward-looking statements and financial projections that are subject to risks and uncertainties that could cause actual results to differ materially.
Pathway Health is one of the largest providers of out-of-hospital pain management services in . The Company owns and operates 9 community-based clinics across 4 provinces where its team of health professionals work together to help patients through a variety of evidence-based approaches. Pathway Health's patient care programs utilize an interdisciplinary approach that is guided by trained pain specialists, physical and occupational therapists, psychologists, nurses, and other healthcare providers. Pathway Health has also developed an expertise in harm reduction where medicinal cannabis is being used as an alternative to traditional opioids.
Global Crossing Airlines - September 1st 2021 Investor Update WebinarThe Howard Group Inc.
Global Crossing Airlines Group Inc. was incorporated under the laws of British Columbia and continued as a Federal
corporation pursuant to the Canada Business Corporations Act effective February 28, 2017. On February 5, 2020, the
Company entered into a definitive agreement with Global Crossing Airlines, Inc. (“Global USA”), a Delaware
corporation, with respect to a business combination of the Company and Global USA (the “Transaction”). On
December 22, 2020, the Company changed its jurisdiction of incorporation from the Province of British Columbia,
Canada to the State of Delaware (the “U.S. Domestication“). In connection with the U.S. domestication, the Company
changed its name to “Global Crossing Airlines Group, Inc.”
The Company’s principal business activity is the start-up of an aircraft, crew, maintenance, insurance (“ACMI”) and
wet lease US charter airline serving the US, Caribbean and Latin American markets. The address of the Company’s
registered office is office is c/o Cogency Global Inc., 850 New Burton Rd, Suite 201, Dover, County of Kent, Delaware
19904. The Company’s shares trade on the TSX Venture Exchange under the symbol “JET” and are quoted on the
OTCQB under the symbol “JETMF”.
Canada Jetlines is a 100% equity financed and well capitalized low-cost tour and charter leisure carrier that will utilize a growing fleet of Airbus 320 aircraft to service popular sun destinations starting in early 2022, subject to Canadian Transport Agency and Transport Canada approval.
For more information about everything Canada Jetlines, please visit www.jetlines.ca.
About Canada Jetlines Operations Ltd.
Canada Jetlines is a 100-per-cent-equity-financed and well-capitalized leisure carrier, which will utilize a growing fleet of Airbus 320 aircraft targeting a start in early 2022, subject to Canadian Transport Agency and Transport Canada approval. The carrier was created to provide Canadian consumers with more value choices and travel options to fly to coveted sun and leisure destinations in the United States, the Caribbean and Mexico. With a projected growth of 15 aircraft by 2025, Canada Jetlines aims to offer the best-in-class operating economics, customer comfort and fly-by-wire technology, providing an elevated guest-centric experience from the first touch point. The carrier will use a state-of-the-art Web booking platform, making the turnkey solution available to travel agents, tour operators and consumers, with the capability of generating revenue on reservations and ancillary sales. The efficient aircraft design, merged with the experience of the all-Canadian management team, allows for accessible flight options without sacrificing quality or convenience.
Pathway Health is one of the largest providers of out-of-hospital pain management services in Canada. We own and operate nine community-based clinics across four provinces where our team of health professionals work together to help patients by using a variety of evidence-based approaches.
Global Crossing is a U.S. 121 domestic flag and supplemental airline flying the Airbus A320 family aircraft. GlobalX flies as an ACMI (aircraft, crew, maintenance and insurance) and charter airline serving the U.S., Caribbean and Latin American markets.
GlobalX is a US 121 domestic flag and supplemental airline flying the Airbus A320 family aircraft. GlobalX has one A320 in revenue operations and has begun the process to add its A321 aircraft onto its certificate subject to FAA and DOT approvals. GlobalX has announced the delivery of its third and fourth aircraft deliveries in the second half of 2021. GlobalX flies as an ACMI and wet lease charter airline serving the US, Caribbean, and Latin American markets. For more information, please visit www.globalxair.com
Global Crossing Airlines (GlobalX) Investor Presentation - TSXV: JET / OTCQB:...The Howard Group Inc.
GlobalX is a new entrant airline now in FAA certification using the Airbus A320 family aircraft. Subject to FAA and DOT approvals, GlobalX intends to fly as an ACMI and wet lease charter airline serving the US, Caribbean and Latin American markets. For more information please visit https://www.globalairlinesgroup.com/.
Global Crossing Airlines provided an investor update on June 30, 2021. Over the past year, the company has achieved key milestones in its plan to launch as a US domestic and international airline, including completing FAA certification testing, recruiting an experienced leadership team, raising over $23 million, and signing aircraft lease and charter contracts. The update discusses the company's progress, future growth plans, and financial outlook.
This document provides information about an initial public offering, including that a preliminary prospectus has been filed with securities regulators containing important information about the securities. The preliminary prospectus is still subject to completion and securities will not be sold until a receipt for the final prospectus has been issued. The document also advises that the preliminary prospectus should be read for full disclosure before making an investment decision.
Global Crossing Airlines / GlobalX Corporate Presentation (JET: TSX-V; JETMF:...The Howard Group Inc.
Global Crossing Airlines is presenting at the 2021 Virtual Transportation & Logistics Conference. The summary discusses:
1) Global Crossing's original investment thesis was to enter the narrowbody charter market with modern aircraft at competitive prices, taking advantage of favorable leasing terms as the aircraft leasing market downturned.
2) COVID-19 significantly increased available aircraft and reduced lease rates while weakening competition and increasing the pool of available pilots and staff, improving Global Crossing's position.
3) Global Crossing aims to operate passenger charters and cargo flights, taking advantage of an opportunity in both markets as existing operators use very old aircraft. They have signed deals for aircraft and are progressing certification.
About Global Crossing Airlines Group Inc.
Global Crossing is a U.S. 121 domestic flag and supplemental airline flying the Airbus A320 family aircraft. GlobalX flies as an ACMI (aircraft, crew, maintenance and insurance) and charter airline serving the U.S., Caribbean and Latin American markets.
This document provides an overview of Constellation Brands' investment in Canopy Growth Corporation and contains forward-looking statements regarding their business strategies, future operations, growth opportunities, and financial projections. It cautions that these statements are based on current expectations and actual results could differ due to various risk factors and uncertainties.
This presentation is provided for informational purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential business combination
between Bespoke Capital Acquisition Corp. (“BCAC”) and Vintage Wine Estates, Inc. (“VWE”) and related transactions (collectively the “Potential Transactions".
GlobalX provides an overview of their business updates and growth plans. They operate a hybrid charter airline model with both passenger and cargo operations. GlobalX has seen strong growth in block hours and expects continued expansion in 2022. They plan to opportunistically acquire additional aircraft to capitalize on recovery in the passenger and cargo markets.
This document summarizes a potential business combination between Bespoke Capital Acquisition Corp. ("BCAC") and Vintage Wine Estates, Inc. ("VWE"). It outlines the attractive investment thesis for combining the companies, including VWE's experienced management team, track record of acquisitions, diversified business model, and strong financial profile. The transaction overview provides details of the proposed enterprise value of $691 million, use of proceeds to repay debt, and post-merger board composition.
Constellation Brands provides an overview presentation for investors on its 2Q'21 results. The presentation contains forward-looking statements regarding Constellation's investments in Canopy Growth and potential benefits. It discusses Canopy's opportunities for growth in international cannabis markets as well as future product development. However, the presentation notes that forward-looking statements are subject to risks and uncertainties that could cause actual results to differ from expectations.
This document provides forward-looking statements and information about Shona Energy Company, Inc. It outlines key assumptions regarding future capital expenditures, oil and gas prices, production levels, exchange rates, financing ability, and other economic factors. It cautions readers that actual results may differ materially from forecasts due to risks in the oil and gas industry and greater economic uncertainties. The document is not a complete analysis of Shona and readers should conduct their own due diligence.
The document is a corporate presentation for Zenabis Global Inc. that provides an overview of the company's history and operations. It notes that Zenabis was formed in January 2019 through the reverse takeover of Bevo Agro Inc. by Sun Pharm Investments Ltd. Bevo Agro had a successful 30+ year history of growing hundreds of unique crops at an industrial scale in British Columbia, with EBITDA growing at 20% annually from 2011 to 2018 and EBITDA margins of around 24% in 2018. The presentation contains standard disclaimer language about forward-looking statements and the purpose of the document being for information only.
The document discusses a proposed business combination between Canacol Energy Ltd. and Shona Energy Company, Inc. announced in October 2012. The transaction would create a larger combined entity with one of the largest and most diverse oil and gas portfolios in Colombia, including assets in the Lower Magdalena Basin with natural gas reserves, the Llanos Basin with existing oil production, and exploration acreage in the Caguan-Putumayo and Middle Magdalena Basins. The transaction is expected to close in December 2012, subject to shareholder approvals.
The document provides an overview of Ero Copper's April 2022 analyst site visit to their MCSA Mining Complex and Boa Esperança project in Brazil. It includes forward-looking statements and cautions that actual results may differ materially from projections. It also notes the qualifications of the experts who prepared technical reports on the company's properties and provides context around non-IFRS financial measures discussed. Key topics to be covered include health, safety and environment; performance and growth opportunities at MCSA and NX Gold; updates on the Boa Esperança project; and the company's balance sheet and financial position.
This presentation provides information about a potential business combination between Bespoke Capital Acquisition Corp. ("BCAC") and Vintage Wine Estates, Inc. ("VWE"). It supersedes all prior presentations on this topic. The presentation is intended to assist parties in evaluating the potential transactions and contains forward-looking statements and projections subject to risks and uncertainties. No representations or warranties are given regarding the information provided.
- Shona Energy Company is an oil and gas exploration and development company focused on assets in Colombia and Peru
- It has existing production and reserves on its Esperanza block in Colombia and exploration blocks in Colombia and Peru
- On its core Esperanza block, Shona has best estimate net reserves of 173 BCF and identified prospects that could add over 100 BCF of potential reserves based on 3D seismic analysis
- WTW reported its 2021 fourth quarter and full year financial results on February 8, 2022.
- For Q4 2021, revenue increased 1% to $2.7 billion. Income from operations grew 19% to $690 million and operating margin expanded 380 basis points to 25.5%.
- For full year 2021, revenue increased 4% to $9 billion. Income from operations jumped 156% to $2.2 billion and operating margin grew 1450 basis points to 24.5%.
1) CanniMed Therapeutics is an international, biopharmaceutical company and leader in the Canadian medical cannabis industry with pharmaceutical-grade products.
2) They have a 15-year history of growing medical cannabis and a first mover advantage in emerging international markets like Australia.
3) Recent results show strong revenue, volume, and EBITDA growth and they have expanded production capacity with government support. The Canadian and international medical cannabis markets provide significant opportunities.
Global Crossing is a U.S. 121 domestic flag and supplemental airline flying the Airbus A320 family aircraft. GlobalX flies as an ACMI (aircraft, crew, maintenance and insurance) and charter airline serving the U.S., Caribbean and Latin American markets.
GlobalX is a US 121 domestic flag and supplemental airline flying the Airbus A320 family aircraft. GlobalX has one A320 in revenue operations and has begun the process to add its A321 aircraft onto its certificate subject to FAA and DOT approvals. GlobalX has announced the delivery of its third and fourth aircraft deliveries in the second half of 2021. GlobalX flies as an ACMI and wet lease charter airline serving the US, Caribbean, and Latin American markets. For more information, please visit www.globalxair.com
Global Crossing Airlines (GlobalX) Investor Presentation - TSXV: JET / OTCQB:...The Howard Group Inc.
GlobalX is a new entrant airline now in FAA certification using the Airbus A320 family aircraft. Subject to FAA and DOT approvals, GlobalX intends to fly as an ACMI and wet lease charter airline serving the US, Caribbean and Latin American markets. For more information please visit https://www.globalairlinesgroup.com/.
Global Crossing Airlines provided an investor update on June 30, 2021. Over the past year, the company has achieved key milestones in its plan to launch as a US domestic and international airline, including completing FAA certification testing, recruiting an experienced leadership team, raising over $23 million, and signing aircraft lease and charter contracts. The update discusses the company's progress, future growth plans, and financial outlook.
This document provides information about an initial public offering, including that a preliminary prospectus has been filed with securities regulators containing important information about the securities. The preliminary prospectus is still subject to completion and securities will not be sold until a receipt for the final prospectus has been issued. The document also advises that the preliminary prospectus should be read for full disclosure before making an investment decision.
Global Crossing Airlines / GlobalX Corporate Presentation (JET: TSX-V; JETMF:...The Howard Group Inc.
Global Crossing Airlines is presenting at the 2021 Virtual Transportation & Logistics Conference. The summary discusses:
1) Global Crossing's original investment thesis was to enter the narrowbody charter market with modern aircraft at competitive prices, taking advantage of favorable leasing terms as the aircraft leasing market downturned.
2) COVID-19 significantly increased available aircraft and reduced lease rates while weakening competition and increasing the pool of available pilots and staff, improving Global Crossing's position.
3) Global Crossing aims to operate passenger charters and cargo flights, taking advantage of an opportunity in both markets as existing operators use very old aircraft. They have signed deals for aircraft and are progressing certification.
About Global Crossing Airlines Group Inc.
Global Crossing is a U.S. 121 domestic flag and supplemental airline flying the Airbus A320 family aircraft. GlobalX flies as an ACMI (aircraft, crew, maintenance and insurance) and charter airline serving the U.S., Caribbean and Latin American markets.
This document provides an overview of Constellation Brands' investment in Canopy Growth Corporation and contains forward-looking statements regarding their business strategies, future operations, growth opportunities, and financial projections. It cautions that these statements are based on current expectations and actual results could differ due to various risk factors and uncertainties.
This presentation is provided for informational purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential business combination
between Bespoke Capital Acquisition Corp. (“BCAC”) and Vintage Wine Estates, Inc. (“VWE”) and related transactions (collectively the “Potential Transactions".
GlobalX provides an overview of their business updates and growth plans. They operate a hybrid charter airline model with both passenger and cargo operations. GlobalX has seen strong growth in block hours and expects continued expansion in 2022. They plan to opportunistically acquire additional aircraft to capitalize on recovery in the passenger and cargo markets.
This document summarizes a potential business combination between Bespoke Capital Acquisition Corp. ("BCAC") and Vintage Wine Estates, Inc. ("VWE"). It outlines the attractive investment thesis for combining the companies, including VWE's experienced management team, track record of acquisitions, diversified business model, and strong financial profile. The transaction overview provides details of the proposed enterprise value of $691 million, use of proceeds to repay debt, and post-merger board composition.
Constellation Brands provides an overview presentation for investors on its 2Q'21 results. The presentation contains forward-looking statements regarding Constellation's investments in Canopy Growth and potential benefits. It discusses Canopy's opportunities for growth in international cannabis markets as well as future product development. However, the presentation notes that forward-looking statements are subject to risks and uncertainties that could cause actual results to differ from expectations.
This document provides forward-looking statements and information about Shona Energy Company, Inc. It outlines key assumptions regarding future capital expenditures, oil and gas prices, production levels, exchange rates, financing ability, and other economic factors. It cautions readers that actual results may differ materially from forecasts due to risks in the oil and gas industry and greater economic uncertainties. The document is not a complete analysis of Shona and readers should conduct their own due diligence.
The document is a corporate presentation for Zenabis Global Inc. that provides an overview of the company's history and operations. It notes that Zenabis was formed in January 2019 through the reverse takeover of Bevo Agro Inc. by Sun Pharm Investments Ltd. Bevo Agro had a successful 30+ year history of growing hundreds of unique crops at an industrial scale in British Columbia, with EBITDA growing at 20% annually from 2011 to 2018 and EBITDA margins of around 24% in 2018. The presentation contains standard disclaimer language about forward-looking statements and the purpose of the document being for information only.
The document discusses a proposed business combination between Canacol Energy Ltd. and Shona Energy Company, Inc. announced in October 2012. The transaction would create a larger combined entity with one of the largest and most diverse oil and gas portfolios in Colombia, including assets in the Lower Magdalena Basin with natural gas reserves, the Llanos Basin with existing oil production, and exploration acreage in the Caguan-Putumayo and Middle Magdalena Basins. The transaction is expected to close in December 2012, subject to shareholder approvals.
The document provides an overview of Ero Copper's April 2022 analyst site visit to their MCSA Mining Complex and Boa Esperança project in Brazil. It includes forward-looking statements and cautions that actual results may differ materially from projections. It also notes the qualifications of the experts who prepared technical reports on the company's properties and provides context around non-IFRS financial measures discussed. Key topics to be covered include health, safety and environment; performance and growth opportunities at MCSA and NX Gold; updates on the Boa Esperança project; and the company's balance sheet and financial position.
This presentation provides information about a potential business combination between Bespoke Capital Acquisition Corp. ("BCAC") and Vintage Wine Estates, Inc. ("VWE"). It supersedes all prior presentations on this topic. The presentation is intended to assist parties in evaluating the potential transactions and contains forward-looking statements and projections subject to risks and uncertainties. No representations or warranties are given regarding the information provided.
- Shona Energy Company is an oil and gas exploration and development company focused on assets in Colombia and Peru
- It has existing production and reserves on its Esperanza block in Colombia and exploration blocks in Colombia and Peru
- On its core Esperanza block, Shona has best estimate net reserves of 173 BCF and identified prospects that could add over 100 BCF of potential reserves based on 3D seismic analysis
- WTW reported its 2021 fourth quarter and full year financial results on February 8, 2022.
- For Q4 2021, revenue increased 1% to $2.7 billion. Income from operations grew 19% to $690 million and operating margin expanded 380 basis points to 25.5%.
- For full year 2021, revenue increased 4% to $9 billion. Income from operations jumped 156% to $2.2 billion and operating margin grew 1450 basis points to 24.5%.
1) CanniMed Therapeutics is an international, biopharmaceutical company and leader in the Canadian medical cannabis industry with pharmaceutical-grade products.
2) They have a 15-year history of growing medical cannabis and a first mover advantage in emerging international markets like Australia.
3) Recent results show strong revenue, volume, and EBITDA growth and they have expanded production capacity with government support. The Canadian and international medical cannabis markets provide significant opportunities.
Real matters Investor Presentation - April 26 2017 redactedrealmatters2016
This document provides information about an initial public offering, including that a preliminary prospectus has been filed with securities regulators containing important information about the securities. The preliminary prospectus is still subject to completion and securities will not be sold until a receipt for the final prospectus has been issued. The document also advises that prospective investors should rely only on the information in the preliminary prospectus and refers readers to risk factors and other disclosures contained therein.
CanniMed Therapeutics Inc. is a leader in the Canadian medical cannabis industry and the first mover in international markets. It has a 15-year history of growing pharmaceutical-grade cannabis and is well positioned for growth through new distribution channels in Canada, increasing production capacity, and pursuing exports to multiple countries. Recent developments include strong Q3 2017 results, entering Canada's first pharmacy distribution agreement, and commencing an expansion of its Cannabis Oils Facility.
Natco Pharma Limited is an integrated pharmaceutical company with operations across India, the US, and rest of world. It has a strong brand presence in oncology in India and is growing its portfolio in cardiology and diabetes. The company focuses on complex generics for the US market through niche Paragraph IV and Paragraph III filings. It has two R&D centers with over 525 employees and is poised for growth in the agricultural chemicals space. For the financial year ending March 2021, Natco Pharma reported total revenues of INR 21,557 million.
Canni med therapeutics inc management presentation - march 2017CannimedTherapeutics
CanniMed Therapeutics is a Canadian pharmaceutical company and leader in the medical cannabis industry with 15 years of experience culturing cannabis. It has a GMP-compliant production process with strict quality control and is conducting the first Health Canada approved Phase IIA clinical trial. CanniMed is focused on producing pharmaceutical-grade cannabis products and developing new delivery methods, such as cannabis oil gelcaps, to appeal to broader medical markets for pain treatment. It aims to address the large market for alternative chronic pain therapies and the needs of aging baby boomers.
Hempacco Co, Inc. is Disrupting Tobacco™ and its nearly $1 trillion industry by manufacturing and selling herb and hemp smokables from San Diego, California. Through its own brands and joint venture businesses, the Company has launched various brands and products, including The Real Stuff, Hemp Hop with rapper Rick Ross, and Cheech & Chong's Hemp Smokables.
Hempacco also provides full-service private label herb and hemp smokables product development, manufacturing, and logistics and owns 600 vending machines to sell its brands. Hempacco is Disrupting Tobacco as it executes its mission to become the most recognized name in herb and hemp smokable products globally.
Patriot Shield provides logistical services for the cannabis and hemp industries, including security, transportation, warehousing, distribution, and consulting. The company was founded by experienced entrepreneurs with a veteran leadership team and has generated over $2 million in revenue in its first year. Patriot Shield aims to expand its operations across multiple states through major distribution agreements and partnerships.
Progyny JP Morgan Presentation January 2023.pdfssuser5105e0
This document provides an overview of Progyny, a benefits company focused on fertility and family building. It discusses Progyny's mission-driven approach, data-driven network management, and track record of superior clinical outcomes. The document also reviews Progyny's growth, highlighting near 100% client retention and expanding coverage to over 5 million lives. It positions Progyny as the only fully-managed family building solution and discusses how its approach delivers tangible value through savings and healthier outcomes compared to alternative programs.
This management presentation discusses Sleep Country Canada's initial public offering. It provides an overview of the company as the leading specialty mattress retailer in Canada, with a national footprint and market leading brand recognition and traffic. The presentation highlights Sleep Country's best-in-class retail strategy focused on an unrivaled in-store customer experience through highly trained staff and superior home delivery. Financial highlights and growth targets are presented, noting the company's attractive financial model and ability to generate strong cash flow. Risk factors and forward-looking statements are also discussed.
Q1 2015 earnings slides monday final reviewinvestorjgwpt
1) The document discusses the company's first quarter 2015 earnings call which reviewed financial results and key initiatives.
2) Total revenues were $62.4 million, adjusted net income was $8.2 million or $0.29 per share, and total receivables purchased were $260.8 million.
3) The company is focused on growing its core business while diversifying into new lines like prepaid and personal lending, and recently acquired a mortgage originator.
This document summarizes an investor presentation for MedReleaf Corp.'s initial public offering. Key points include that MedReleaf is offering shares at $9.50-$10.50 per share to raise approximately $100 million Canadian dollars, which will be used to expand their existing cannabis production facility, develop new products, and for general corporate purposes. Investors are warned to consider the risks disclosed in the prospectus and that forward-looking statements are based on estimates and assumptions. The presentation highlights MedReleaf's current operational success, low production costs, high market share, and near-term expansion plans.
This document summarizes an investor presentation for MedReleaf Corp.'s initial public offering. Key points include that MedReleaf is seeking to raise approximately $100 million Canadian dollars in an IPO priced between $9.50-$10.50 per share. Proceeds will be used to expand MedReleaf's existing cannabis production and manufacturing facilities, fund clinical research, and for general working capital purposes. The presentation highlights MedReleaf's current operational success and leadership in the Canadian medical cannabis market.
This document summarizes an investor presentation for MedReleaf Corp.'s initial public offering. It outlines key details of the offering such as the issuer, selling shareholders, offering price range between $9.50-$10.50 per share, expected size of $100 million, and intended use of proceeds. It also highlights MedReleaf's leadership in the Canadian medical cannabis market through its high quality indoor cultivation facilities, low production costs, revenue growth while maintaining profitability, and plans for expansion.
The Health & Wellness market in the UK was valued at £23bn in 2020, an increase from £20.5bn in 2015. Total healthcare, wellness and fitness spending in the UK reached £209bn in 2020. Pure Restore Health provides innovative treatments and therapies utilizing the latest healthcare technologies to help people feel their best by addressing issues like chronic pain, injury recovery, athletic performance and more.
Avicanna is a biopharmaceutical company focused on developing and commercializing plant-derived cannabinoid-based products. They have a scientific platform and R&D capabilities for product development as well as commercial operations across 18 international markets. Their product portfolio includes over 20 proprietary formulations under their medical and wellness brand RHO Phyto as well as a pharmaceutical CBD drug preparation pending market authorization. Avicanna also has a pharmaceutical pipeline of cannabinoid-based drug candidates targeting neurological, dermatological and pain indications.
Max Healthcare Institute Limited's investor presentation provides an overview of the company and its growth drivers. It highlights the following key points in 3 sentences:
Max Healthcare is India's second largest hospital chain in terms of revenue, EBITDA and market capitalization, with a dominant presence in the largest and most profitable markets of Delhi NCR and Mumbai. It has a vision to be the most well regarded healthcare provider in India committed to clinical excellence, cutting edge technology, and research. The presentation outlines Max Healthcare's track record, strategic focus areas, and financial performance to position it for continued strong growth and profitable expansion.
Hemptown Spring 2019 Investor PresentationHemptown USA
From the rich soils of Southern Oregon's Emerald Triangle, Hemptown USA is producing some of the finest cannabinoid products in the world.
Hemptown USA’s toolkit is a unique one. Combined with our vertically integrated business model we are in firmly positioned to capitalize on a global market expected to exceed $22 billion by 2020.
TCF Financial Corporation held an investor presentation on February 11, 2020 to discuss the merger with Chemical Financial Corporation. The presentation highlighted that the combined company will be a premier Midwest bank with $47 billion in total assets and $34 billion in loans and deposits each. It was noted that the merger of equals will create scale and product offerings to better compete in key Midwest markets. The new company will have a commercial loan focus of 67% and consumer loans of 33%. The presentation also introduced the new purpose and beliefs of the combined organization to unite the cultures as One TCF and outlined the experienced management team and their ability to recruit top talent for the larger regional bank.
Similar to Pathway health corporate presentation (june 2021) (20)
About Temas Resources Corp.
The company is focused on the advancement of mineral independence and processes by which minerals are extracted in an environmentally friendly manner. The company invests in and works to apply green technology across its mining portfolio to reduce the environmental impact and carbon footprint of metal extraction through advanced processing and patented leaching technologies. The company is advancing iron-titanium-vanadium projects in Quebec and soon expects to be active at its boron projects in Serbia.
About Progressive Planet Solutions Inc.
Progressive Planet is an emerging company, providing innovative circular solutions and Earth-friendly micronized minerals that naturally unlock sustainability benefits across the construction and agriculture industries. Tapping into the Earth's inherent binding powers and properties, Progressive Planet is developing and scaling a portfolio of proprietary solutions to help its customers build, grow and operate more responsibly.
Progressive Planet continues work on creating supplementary cementing materials with a focus on minimizing the carbon footprint of the SCMs it creates, utilizing waste materials where possible to create the most sustainable SCMs and sequestering carbon dioxide in SCMs to address climate change. Progressive Planet's research team has begun exploring the opportunity to utilize the legacy CO2 stream generated by APL's natural gas rotary kiln dryer in operation in Kamloops.
Progressive Planet's operations currently include:
A comminution facility in Spallumcheen, B.C., which is currently producing micronized minerals used by farmers in lieu of chemical fertilizers to promote healthy soils without the addition of chemicals;
A research lab in Calgary, Alta., focused on creating SCMs and associated technologies to sequester CO2 in concrete;
Three natural pozzolan properties in British Columbia, including its flagship Z1 natural pozzolan quarry in Cache Creek, B.C., and its two pozzolan properties under development, the Z2 natural pozzolan property near Falkland and the Heffley Creek metal and natural pozzolan property.
The document provides an overview of Thesis Gold's Ranch Gold-Copper Project located in northern British Columbia. Key points include:
- The project covers over 18,000 hectares of underexplored land with over 20 historical precious metal occurrences.
- A 16,000 meter drilling program in 2021 aimed to confirm and expand on high-grade drill results including 19.6 g/t Au over 34 meters.
- Surface exploration including over 7,400 soil and 700 rock samples is ongoing to generate new targets.
- Initial drilling results from the Bonanza Zone were positive and confirmed high-grade gold mineralization over broad intervals.
Cematrix is a rapidly growing, cash-flow-positive company that manufactures and supplies technologically advanced cellular concrete products developed from proprietary formulations across North America. This unique cement-based material with superior thermal protection delivers cost-effective, innovative solutions to a broad range of problems facing the infrastructure, industrial (including oil and gas) and commercial markets. Through recent acquisitions of Chicago-based MOS and Bellingham-based Pacific International Grout, Cematrix is now North America's largest cellular concrete company.
Thesis Gold is a mineral exploration company focused on proving and developing the resource potential of the 17,832-hectare Ranch gold project located in the Golden Horseshoe area of Northern British Columbia, approximately 300 kilometres north of Smithers, B.C.
Cematrix is a leading provider of cellular concrete technology. The presentation provides an overview of Cematrix, including their focus on sustainability and proprietary technologies. It also outlines their growth strategy, which involves regional expansion, mergers and acquisitions, and strategic alliances. Cematrix has achieved major milestones and endured through a history in the industry since going public in 2006.
Thesis Gold is a mineral exploration company focused on proving and developing the resource potential of the 17,832-hectare Ranch gold project located in the Golden Horseshoe area of Northern British Columbia, approximately 300 kilometres north of Smithers, B.C.
Global Crossing Airlines (GlobalX) is the newest entrant to the charter/cargo space in the US. The company was created from a reverse takeover of Canada Jetlines in June 2020.
AirTest Technologies Inc. (TSX-V: AAT) is a rapidly-growing green tech company specializing in sensors that significantly improve commercial building operating efficiency. AirTest's leading-edge, proprietary sensor technologies improve the energy performance, environmental impact and return on investment for the millions of buildings we all work, shop and play in. We work with existing building contractors, building owners, property management companies, energy management companies and large equipment and controls manufacturers.
Drawing on innovations originating from the medical, electronics, telecommunication and automotive field, AirTest offers a growing portfolio of sensor products that meet the unique needs of the "buildings" industry along with application tools and cutting edge communication technologies that will ensure the easy and cost effective migration of these technologies to all buildings."
Thesis Gold is a mineral exploration company focused on proving and developing the resource potential of the 17,832-hectare Ranch gold project located in the Golden Horseshoe area of northern British Columbia, approximately 300 km north of Smithers, B.C. For further details about the Ranch Gold Project, please refer to the company's current geological technical report dated Sept. 18, 2020, available under the company's profile on SEDAR.
PLAN is developing technologies and materials to reduce the carbon footprint of cement production and create more sustainable concrete. Their flagship product, PozGlass SCM, aims to replace Portland cement by combining natural pozzolan with recycled glass to produce a supplementary cementitious material. This has the potential to sequester carbon dioxide during the curing process. If successful, PozGlass SCM could be used in most concrete applications like buildings and infrastructure, diverting waste glass from landfills. PLAN is also exploring using natural pozzolans and other products to sequester carbon in soil as a way to offset cement emissions.
1) Mineworx has developed a chemical process to extract precious metals like platinum and palladium from catalytic converters, providing a solution for recyclers currently unable to process diesel converters.
2) A pilot plant is being constructed and tested to optimize the process, with commercialization planned for late 2021.
3) The technology is expected to generate over $100 million in annual revenue from an initial commercial plant processing 10 tonnes per day, capturing a 20% gross margin.
This corporate presentation provides an overview of CEMATRIX, a leading on-site manufacturer and installer of cellular concrete. Some key points:
- CEMATRIX utilizes proprietary technologies to provide infrastructure construction solutions using cellular concrete, which is generally more sustainable than legacy products.
- They have a growing backlog exceeding $94M as of June 2021 and are focused on infrastructure projects benefiting from government spending.
- CEMATRIX has a strategic partnership with Lafarge, the largest global building materials company, providing supply agreements and joint marketing opportunities.
- Cellular concrete is lightweight, strong, and more environmentally friendly than traditional fills or insulations, making it a valuable construction material.
PLAN is developing technologies to reduce the carbon footprint of cement production and concrete. Their flagship product, PozGlass SCM, aims to replace Portland cement in concrete with a more sustainable blend containing natural pozzolan and recycled glass that can also sequester carbon dioxide. If successful, PozGlass SCM could divert waste glass from landfills while making concrete that is stronger and has a lower carbon footprint than conventional concrete. PLAN is also exploring using soil and other cement products to capture and store carbon dioxide from industrial emissions on a large scale.
PLAN is developing technologies to reduce the carbon footprint of cement production and concrete. Their flagship product, PozGlass SCM, aims to replace Portland cement in concrete with a more sustainable blend containing natural pozzolan and recycled glass that can also sequester carbon dioxide. If successful, PozGlass SCM could divert waste glass from landfills while making concrete that is stronger and has a lower carbon footprint than conventional concrete. PLAN is also exploring using soil and cement applications to permanently sequester additional carbon dioxide from industrial sources.
The presentation summarizes Thesis Gold's Ranch Gold Project located in British Columbia's Golden Horseshoe region. The Ranch Project covers over 178 square kilometers and contains 21 known near-surface epithermal gold deposits with historical drilling averaging less than 100 meters in depth. Thesis plans an aggressive 20,000 meter drilling campaign starting in July 2021 to further define resources across the property, where mineralization at existing zones remains open along strike and at depth. The team is experienced in the region and aims to rapidly delineate the substantial exploration potential through data compilation, geological mapping, geophysics, and an initial fully funded drill program.
Progressive Planet is developing technologies to decarbonize cement production, including PozGlass SCM and C-Quester Cellular Concrete. PozGlass combines natural pozzolan and recycled glass to reduce CO2 emissions in concrete, while C-Quester aims to permanently sequester CO2 in cellular concrete. Testing of PozGlass is underway, with commercial production planned for 2022 to replace fly ash and reduce the cement industry's environmental impact.
This corporate presentation from CEMATRIX provides an overview of the company and its cellular concrete technology. CEMATRIX manufactures and installs cellular concrete on site across North America using proprietary technologies. Cellular concrete is a more sustainable and environmentally friendly alternative to other materials like EPS blocks and rigid insulations. The presentation highlights CEMATRIX's strategic partnership with Lafarge, its growth strategy through acquisitions, and its focus on infrastructure, industrial, and commercial end markets.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
2. page 2
DISCLAIMER
Certain statements contained in this presentation constitute forward-looking statements. The words “anticipate”,
“continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions typically are
used to identify forward-looking statements. By their nature, forward-looking statements and information involve
known and unknown opportunities, costs, risks and uncertainties that may cause actual results to differ materially
from those anticipated. Except for statements of historical fact, certain information contained herein constitutes
forward-looking statements which include management’s assessment of future plans and operations and are based
on current internal expectations, estimates, projections, assumptions and beliefs, which may prove to be incorrect.
The use of forward-looking statements reflects our current views, expectations, estimates and/or projections with
respect to our performance, business and future events, and in this presentation includes statements relating to,
among others: expectations regarding our business; expectations relating to our business goals, objectives and
schedules; expectations regarding the cannabinoid based therapy industry, including Canada’s position therein;
expectations regarding the acceptance of cannabinoid based therapies in the medical community; expectations
regarding our clinical development plans; expectations regarding development of new intellectual property, including
from cannabinoid product combinations; expectations related to the anticipated closing of the subscription receipt
offering and reverse take-over with a Capital Pool Company; the terms and conditions of the subscription receipt
offering; and the use of proceeds from the subscription receipt offering. Forward-looking statements are prepared by
management and based on the then-current expectations, forecasts and assumptions about the business and the
industry and markets in which we operate, including, among others: that there will be no unforeseen delays,
disruptions, market forces, regulations or laws that will prevent us from operating our business; that we will be able
to obtain the capital we require; that the subscription receipt offering has closed; that the escrow release conditions
in respect of the subscription receipt offering have been fulfilled; and that the reverse take-over has been completed.
Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and
assumptions which are difficult to predict, including, without limitation: that we may experience unforeseen delays,
financing difficulties or costs that will impact our projects, operations, financial performance or liquidity; that we will
not be able to advance our business plan or continue operations; that we will not be able to obtain insurance for our
operations; that we will not be able to protect our intellectual property; that we will not be able to develop and
commercialize, or obtain regulatory approvals to commercialize, products derived from our intellectual property; that
we will not be able to recruit physicians for our clinics; that regulatory approvals of products developed from our
intellectual property may result in significant delays; that development of cannabinoid based therapies may expose
us to liability claims in excess of our insurance coverage; and those risks relating to the occurrence of national
disasters, hostilities, acts of war or terrorism, our reputation, our key personnel, competition, employee relations,
changes in the cannabinoid based therapy market generally, potential downturns in economic conditions, pandemics,
foreign exchange fluctuations, fluctuations in the currency markets, inflationary pressures, changes in interest rates,
changes in regulatory requirements which may alter or prohibit investment in our business, or changes in national
and local government legislation, taxation, controls, regulations and political or economic developments in Canada or
any other country in which we operate or intend to operate.
These risks, as well as others, could cause actual results and events to differ materially from those anticipated in
such forward-looking statements. Accordingly, readers should not place undue reliance on forward-looking
statements and information, which are qualified in their entirety by this cautionary statement. These statements
speak only as of the date of this presentation and we do not undertake any obligations to update such forward-
looking statements, except as required by applicable securities law.
To the extent any forward-looking information in this presentation constitutes “future-oriented financial
information” or “financial outlooks” within the meaning of applicable Canadian securities laws, such information is
being provided to demonstrate the potential benefits of the company’s business plans and strategies, and the reader
is cautioned that this information may not be appropriate for any other purpose and the reader should not place
undue reliance on such future-oriented financial information and financial outlooks. Future-oriented financial
information and financial outlooks, as with forward-looking information generally, are, without limitation, based on
the assumptions and subject to the risks set out herein. The company’s results of operations and estimated and
forecasted revenue may differ materially from management’s current expectations. Such information is presented
for illustrative purposes only and may not be an indication of the company’s actual future results of operations or
earnings.
Market and industry data contained in this presentation is based upon information, surveys or studies conducted by
independent third parties and independent industry or general publications and management’s knowledge of, and
experience in, the markets in which we operate or intend to operate. We have no reason to believe that such third-
party information is false or misleading in any material respect, however market and industry data is subject to
variation and cannot be verified with complete certainty due to limits on the availability and reliability of raw data,
the voluntary nature of the data gathering process and other limitations and uncertainties inherent in any statistical
survey. This third-party information has not been independently verified by us or any of our respective directors,
officers or representatives and no representation is given as to the accuracy of any of the data from third party
sources referred to in this presentation.
The securities being offered pursuant to the subscription receipt offering are being offered on a private placement
basis in reliance upon prospectus and registration exemptions under applicable securities legislation. Resale of the
securities offered hereunder will be subject to restrictions under applicable securities legislation, which will vary
depending on the relevant jurisdiction. Generally, such securities may be resold only pursuant to an exemption from
the prospectus and registration requirements of applicable securities legislation or pursuant to an exemption order
granted by appropriate securities regulatory authorities.
The securities being offered pursuant to the subscription receipt offering have not, nor will they be, registered under
the United States Securities Act of 1933, as amended, or the securities laws of any state of the United States and may
not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons in the absence of
U.S. registration or an applicable exemption from the U.S. registration requirements. This presentation does not
constitutes an offer for sale of securities in the United States.
FORWARD LOOKING STATEMENTS
3. page 3
INVESTMENT HIGHLIGHTS
• One of the largest providers of chronic pain services in
Canada
• 9 pain clinic locations across Canada
• 3-year revenue growth - $600k (2018) to $12.6 million
(2020) 1
• Largest medical cannabis telehealth network in Canada
• Leading partner with Canadian pharmacy companies for
medical cannabis
• MySpark TM proprietary IT – ‘actionable digital
intelligence’
• $13.8 million over subscribed financing (March 2021)
• Anticipated TSX.V trading – early-June/21 (PHC.V)
1. These are unaudited revenue figures. The revenue figures include management's best estimate of additional revenue in relation to the acquisition
of NHS, NACM Clinic and Pharmacy business and NMI as if it happened January 1, 2020.
4. LEADERSHIP TEAM
page 4
Wayne Cockburn
President
Aura Balboa
CFO
Ken Yoon
CEO
Over 25 years of healthcare experience, including
20 years at the C-level, specializing in strategic
planning, corporate finance and capital market
strategies, corporate partnering, corporate
governance and mergers and acquisitions. Mr.
Cockburn brings over 35 years of capital market
experience and has served on the board of
directors of U.S. and Canadian private and public
companies for more than 20 years.
Over 15 years of finance and operations
experience to PHC. Ms. Balboa began her career
in public accounting with Deloitte. She then held
a number of finance roles with increasing
responsibilities at multiple pharmaceutical
companies both in Canada and the US. Her most
recent role was Director of Finance at Acerus
Pharmaceuticals Corporation, a Canadian
pharmaceutical company listed on the TSX.
25 years of experience in consulting, financing,
investing and building innovative private and
public companies with over $500M in
transactions. Prior to PHC, Mr. Yoon was CFO at a
TSX listed pharmaceutical company and a private
nanotech company, an investment professional at
what was one of largest venture capital firms in
Canada, and held several positions at Ernst &
Young, notably as a co-founder of a multi-
disciplinary business advisory group. Mr. Yoon is a
CPA, CA, holds an MBA, Law Degree, and BSc.
5. page 5
Over 30 years of executive level leadership
experience in healthcare. Mr. Wei has a track
record for developing and delivering innovative
allopathic and complementary medicine models
in North America.
Mr. Wei is a co-founder of The Clinic Network
and has helped grow PHC to be a Canadian
delivery system with corporate and joint-venture
clinics, in multiple healthcare disciplines. Mr.
Wei has acted as a Director on multiple Canadian
and international company Boards.
Over 20 years of experience in the healthcare
industry in a variety of capacities and increasingly
senior roles, including sales, business
development, and operations. Prior to joining
PHC, Ms. John was VP of Operations for Agility
Health. For over a decade, she previously served
as Director, Western CDA Sales and Operations at
Shoppers Home Health Care, a division of
Shoppers Drug Mart, where she was responsible
for a diverse six figure portfolio. Ms. John holds
an Executive MBA from the Ivey School of
Business -University of Western Ontario.
Over 20 years of experience in various facets of
the healthcare sector. Mr. Sandhu is the former VP
of Medical Operations and Business Optimization
for National Access Cannabis Medical. Mr. Sandhu
is also an active clinical pharmacist, who has a
passion for developing innovative programs in
regulated environments. In 2014, he was a
recipient of the Trillium Health Partners Allied
Health Professional Award. Mr. Sandhu holds a
Professional Certificate in Cannabis Science and
Medicine from the University of Vermont’s Larner
College of Medicine.
Kim Wei
Chief Commercial Officer
Renee John
VP, Clinic Operations
Pram Sandhu
VP, Pharmacy Programs & Regulatory Affairs
LEADERSHIP TEAM
6. page 6
PREVALENT
1 in 5 Canadian adults
experience chronic pain 1
LACK OF SPECIALISTS
Specialized pain services
are largely inaccessible
BURDENSOME
>$50 billion in health
care resources and
productivity losses 2
UNDER CAPACITY
1-3 Years average wait time
for treatment at publicly-
funded pain clinics in
Canada 3
1 Schopflocher et al., 2011; Reitsma et al., 2011; Steingrimsdottir et al., 2017, Canadian Pain Task Force Report, June 2019
2 https://www.benefitscanada.com/benefits/health-benefits/chronic-pain-costs-employers-52439
3 http://www.canada.com/health/live+this+life+pain+Canadians+with+chronic+pain+struggling+find+help+hope/5485154/story.html
CHRONIC PAIN–A LARGE AND GROWING PROBLEM
7. The Opportunity
page 7
• Fragmented industry – opportunity for consolidator
• Accretive acquisitions - build on existing
infrastructure
• Pharmacy partnerships
• Cannabis 3.0 (2021/22) – focus on medical; opioid
harm reduction; public dialogue of alternative
approaches to pain management
• Partnering opportunities – Workers Comp, unions,
insurance companies, family medical practices, allied
health, LPs, First Nations, government, clinical trials
• Improve access for patients
8. page 8
BUSINESS UNITS
• Network of pain clinics in
major markets across
Canada
• Interdisciplinary
procedures by trained
pain specialists
• Largest medical cannabis
telehealth network in the
country
• Pharmacy partnerships
• MY SPARK TM
• Web-based platform
• Proprietary data
management system
• Referral portal for
doctors, allied health
clinicians, nurses,
pharmacists, patients
• Creating an online
community
• Slawner Ortho (Est. 1952)
• Leader in Montreal (and
surrounding areas) in
Orthotics, Prosthetics, and
Home Healthcare products
• Cannabis Health Products
for clinics and pharmacy
partners (in discussions)
• Co-branding
opportunities
Innovations
Products
Services
9. page 9
SERVICES GROWTH PLANS (2021/22)
• Current 9 locations include Toronto,
Montreal (3), Chateauguay, Magog,
Saskatoon, Winnipeg, Selkirk
• Goal of 12 – 15 clinics across Canada
• Established clinics targeted for BC,
AB and East Coast through acquisition
or affiliation
• Locations for pain/harm reduction
referrals
• Expansion of interventional pain model
into current locations – ketamine
infusions, image-guided therapies, etc.
10. page 10
SERVICES AND PRODUCTS
- GROWTH PLANS (2021)
• Acquisition of new patients
• Accretive to existing active base of >50,000
patients
• Pharmacy referrals for medical cannabis, chronic
pain and harm reduction
• Development of proprietary Cannabis Health
Products (CHPs)
• Exploring Medical Sales License Without
Possession (Health Canada) for B2B (pharmacies)
and B2C sales (clinics)
• Pharmacies – products, co-branding opportunities
11. PHARMACY INITIATIVES
page 11
1. PHARMACIST EDUCATION & CERTIFICATION
Canadian Council on Continuing Education in Pharmacy medical
cannabis education for pharmacists for provincial accreditation
(bilingual) - program owned by, and exclusive to PHC
2. PATIENT REFERRALS
Goal - to become preferred chronic pain telemedicine provider to
Canadian pharmacies
Education/marketing support to pharmacies; refine dosing; Circle of
Care
3. PRODUCT DEVELOPMENT & DISTRIBUTION
Secure retail pharmacy shelf space for future CBD OTC product
distribution
12. page 12
“Preparing pharmacy professionals to play an active, and appropriate,
role in the rapidly evolving world of cannabis”
• Cannabis 3.0 - bringing the benefits of cannabis derivatives (e.g. CBD) into mainstream health
products
• New consumer packaged goods category – pharmacies have limited or no experience with
the category
• PHC is an expert in subject matter – national, medical, credible partner for pharmacies
• Canada has approximately 42,500 licensed pharmacists working in more than 10,000 pharmacies 1
• PHC has signed agreements with several national pharmacy providers to-date
• Targeting >2,000 retail pharmacies covered by agreements by Q4/21
CANNABIS 3.0 AND PHARMACY PARTNERSHIPS
Pharmacy Connection August 30, 2018
1 Canadian Pharmacists Association, https://www.pharmacists.ca/pharmacy-in-
canada/pharmacists-in-canada/
13. page 13
EXPANSION OF PRODUCT DEVELOPMENT AND DISTRIBUTION
1 https://mjbizdaily.com/chart-week-profit-margins-infused-products-can-sky-high/
Distribution network includes PHC’s
>350,000 patient database and
national pharmacy partners
Co-branding opportunities with
pharmacy partners for
preferential shelf space
Exclusive rights to proprietary
delivery system for increased
absorption of active ingredients - for
use with pharmacy and LP partners
CBD-infused products generally
have gross margins higher than
pharmaceutical drugs, wine, beer,
liquor and cigarettes 1
14. PLPs 1
MY SPARKTM –ACTIONABLE DIGITAL INTELLIGENCE
page 14
Physicians
Pharmacies
MY
1. Preferred Licensed Producers
Patient
Portal
15. page 15
FINANCIAL OVERVIEW
LP Revenue Provincial Billing Non-Insured Billing Product Sales
31.4%
46.8%
17.8%
4%
2018
Revenue (C$MM) 2
$12.6
$6.6
$0.6
2020E
2019
$3.9
• Education and
marketing revenue
• 100% gross margins
$5.9
• Physician billings
• 20% gross margins1
$0.5
• Patient private pay
• 80% gross margins
$2.2
• Quebec orthopaedic sales
• 70% gross margins
1. Gross margins on Provincial Billings expected to increase as further integration of recent acquisitions occurs.
2. These are unaudited revenue figures. The revenue figures include management's best estimate of additional revenue in relation to the acquisition
of NHS, NACM Clinic and Pharmacy business and NMI as if it happened January 1, 2020.
16. page 16
INDUSTRY COMPARABLES
Akumin Inc.
Carebook Technologies Inc.
CloudMD Software and Services Inc.
Empower Clinics
Greenbrook TMS Inc.
Jack Nathan Health
MCI OneHealth
Medical Facilities Corp.
MindBeacon Holdings Inc.
Neupath Health Inc.
Skylight Health
ThinkResearch (TRC Holdings)
VitalHub Corp
WELL Health Technologies
1. High and low removed.
-
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
2020 2021 2020 2021
TEV/Rev PRICE/SALES
Median Mean Pathway Health
17. page 17
Percentage Shares
Investor Group Ownership Outstanding
Cura-Can Health Corp. 55.5% 51,638,711
Convertible notes 11.6% 10,864,108
CPC (Colson Capital) 3.1% 2,856,171
Canaccord sub receipts 29.6% 27,600,000
Shares to Agents 0.2% 150,000
GRAND TOTAL 100% 93,108,990
CAP STRUCTURE
113,497,218 fully diluted shares outstanding. No derivative securities
have an exercise price less than issue price of $0.50 per share
18. SUMMARY
page 18
• >10,000 patient visits in 2020
• TCN completed 5 acquisitions since January 2019 to become the nation’s largest
chronic pain telemedicine network. Growing database of more than 350,000
patients for product distribution and data analytics.
Largest out-of-
hospital chronic
pain clinic in
Canada
Proven execution
and strategic
growth
• Revenue has grown from $600K to almost $13 million in 3 years. 1
• Signed 6 agreements in 2020 with some of the nation’s largest retail pharmacies
becoming the leading referral partner for pain products and services for
thousands of Canadian pharmacies.
• Developing a unique IT platform allowing the company to scale pharmacy
initiative and expand its telemedicine services to many physicians.
• Expertise and experience to grow the business to become the dominant out-of-
hospital pain management business in Canada.
Proven
management
1. These are unaudited revenue figures. The revenue figures include management's best estimate of additional revenue in relation to
the acquisition of NHS, NACM Clinic and Pharmacy business and NMI as if it happened January 1, 2020.
19. page 19
Wayne Cockburn,
President
(905) 505-0770
wayne.cockburn@pathwayhealth.ca
Investor Relations
Dave Burwell,
Vice President, The Howard Group
(403) 410-7907
dave@howardgroupinc.com
Contact Information